Clinical trial Recruiting at 1 site Interventional Ages 18 to 35

Saphenous nerve release for patellofemoral (anterior knee) pain

Official title: EFFECT OF SAPHENOUS NERVE RELEASE ON PAIN,BALANCE AND FUNCTION IN PATIENTS WITH PATELLOFEMORAL PAIN SYNDROME

Run by Cairo University · NCT07318987 · Data updated 2026-11-12

This trial will try a manual saphenous nerve release to reduce pain and improve knee function and balance in adults 18–35 with patellofemoral pain who have a positive saphenous neurodynamic test.

More Patellofemoral Pain Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexAll
Enrollment36 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedOctober 10, 2025
Main results expectedJanuary 10, 2026
Study endsJanuary 27, 2026
Registry record updatedJanuary 6, 2026
Trial IDNCT07318987 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–35 with BMI 18–25 who have had anterior knee pain for at least six weeks and a positive saphenous neurodynamic test are the ideal candidates.

Probably not a fit

People with prior knee surgery, recent intraarticular injections, other defined knee pathologies, systemic neuropathic conditions like diabetic neuropathy or fibromyalgia, or significant joint disease are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patellofemoral pain syndrome commonly causes anterior knee pain in young active adults and is usually treated with quadriceps and hip exercise programs. This interventional study targets a possible neural contributor by applying a manual saphenous nerve release to participants with a positive saphenous neurodynamic test. Eligible participants (age 18–35, BMI 18–25, anterior knee pain ≥6 weeks) will receive the nerve-focused manual therapy and be measured for changes in pain, knee function, and balance before and after the intervention. The work is conducted at the Faculty of Physical Therapy, Cairo University, as a supplement to conventional PFPS rehabilitation approaches.

Why it matters

Potential benefit: If effective, adding saphenous nerve release could reduce anterior knee pain and improve functional performance and balance beyond exercise-only rehabilitation.

How similar studies have gone: Direct evidence for saphenous nerve release in PFPS is limited and this approach is relatively novel, though peripheral nerve mobilization techniques have shown some benefit in related musculoskeletal conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1 - Age from 18 to 35 and BMI 18 to 25 kg/m2. 2. Both gender (male and female) 3. Patients who had anterior knee pain for at least six weeks 4. Patients with positive saphenous neurodynamic test (SAPHNT)

Exclusion Criteria:

1. Knee replacement
2. An intraarticular injection within the past 3 months
3. Previous operative treatment or arthroscopy, other secondary knee-related problems (bursitis, tendinopathy, osteochondritis, neuromas, intraarticular pathology (such as osteoarthritis), tumor, and rheumatologic diseases
4. Diabetic neuropathic pain or fibromyalgia

Where it's running

  • Faculty of Physical Therapy, Cairo University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.